Vyome Share Price

Vyome Share Price

NASDAQ: HIND | Healthcare
$0.00
-$1.51 (--%)
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Vyome Stock Performance

Open
N/A
Prev. Close
$1.51
Circuit Range
N/A
Day Range
N/A
Year Range
$1.51 - $5.79
Volume
N/A
Average Traded
N/A

Vyome Share Price Chart

Line chart of the Vyome price trend over the selected period. The price fell overall, ranging from 1.50 to 1.54, ending at 1.51.
$0.00$0.00
L
Show Current Price
H

Vyome Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.58
Revenue (TTM)
$320.00M
Return On Equity (TTM)
-76.26%
Profit Margin
-3281.25%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
39.46%

Vyome Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.04$0.03$0.03$0.06
Net Profit-$1.47-$1.02-$0.69-$0.89
Net Profit Margin-3675.00%-3400.00%-2300.00%-1483.33%
Income ChangeN/A30.61%32.35%-28.99%

Vyome Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$0.32
Net Profit-$10.50
Net Profit Margin-3281.25%
Income ChangeN/A

Vyome Balance Sheet

All figures in USD Million

Particulars2025
Non Current Assets1.06
Current Assets5.44
Total Assets6.5
Non Current Liabilities0.0
Current Liabilities2.74
Total Liabilities2.74
Shareholders' Equity3.76

Vyome Cash Flow

Annually
Particulars2025
Operating (USD Million)-3.75
Investing (USD Billion)0.0
Financing (USD Million)8.65

Corporate Actions

Split
Ex-date: 15 Aug 2025

About Vyome

Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.

Vyome Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.82
$1.51
-17.03%
Oct 2026
$1.92
$1.82
-4.71%
Sep 2026
$2.17
$1.91
-15.49%
Aug 2026
$2.18
$2.26
+7.62%
Jul 2026
$2.24
$2.10
-5.41%
Jun 2026
$2.33
$2.22
-6.33%
May 2026
$2.07
$2.37
+8.72%
Apr 2026
$2.26
$2.18
+2.83%
Mar 2026
$3.33
$2.12
-37.28%
Feb 2026
$1.89
$3.38
+78.36%
Jan 2026
$3.49
$1.90
-44.91%
Dec 2025
$5.13
$3.44
-23.73%

Vyome Share Price FAQs